Matches in SemOpenAlex for { <https://semopenalex.org/work/W2608649154> ?p ?o ?g. }
- W2608649154 endingPage "762" @default.
- W2608649154 startingPage "753" @default.
- W2608649154 abstract "Diabetic nephropathy (DN) is a major cause of end-stage renal disease, and therapeutic options for preventing its progression are limited. To identify novel therapeutic strategies, we studied protective factors for DN using proteomics on glomeruli from individuals with extreme duration of diabetes (ł50 years) without DN and those with histologic signs of DN. Enzymes in the glycolytic, sorbitol, methylglyoxal and mitochondrial pathways were elevated in individuals without DN. In particular, pyruvate kinase M2 (PKM2) expression and activity were upregulated. Mechanistically, we showed that hyperglycemia and diabetes decreased PKM2 tetramer formation and activity by sulfenylation in mouse glomeruli and cultured podocytes. Pkm-knockdown immortalized mouse podocytes had higher levels of toxic glucose metabolites, mitochondrial dysfunction and apoptosis. Podocyte-specific Pkm2-knockout (KO) mice with diabetes developed worse albuminuria and glomerular pathology. Conversely, we found that pharmacological activation of PKM2 by a small-molecule PKM2 activator, TEPP-46, reversed hyperglycemia-induced elevation in toxic glucose metabolites and mitochondrial dysfunction, partially by increasing glycolytic flux and PGC-1α mRNA in cultured podocytes. In intervention studies using DBA2/J and Nos3 (eNos) KO mouse models of diabetes, TEPP-46 treatment reversed metabolic abnormalities, mitochondrial dysfunction and kidney pathology. Thus, PKM2 activation may protect against DN by increasing glucose metabolic flux, inhibiting the production of toxic glucose metabolites and inducing mitochondrial biogenesis to restore mitochondrial function." @default.
- W2608649154 created "2017-05-05" @default.
- W2608649154 creator A5008190831 @default.
- W2608649154 creator A5009528569 @default.
- W2608649154 creator A5009936313 @default.
- W2608649154 creator A5014942240 @default.
- W2608649154 creator A5015048943 @default.
- W2608649154 creator A5020601596 @default.
- W2608649154 creator A5026005041 @default.
- W2608649154 creator A5040787267 @default.
- W2608649154 creator A5043024058 @default.
- W2608649154 creator A5045404629 @default.
- W2608649154 creator A5046765991 @default.
- W2608649154 creator A5047123077 @default.
- W2608649154 creator A5057087677 @default.
- W2608649154 creator A5060129818 @default.
- W2608649154 creator A5061650665 @default.
- W2608649154 creator A5061950265 @default.
- W2608649154 creator A5062039155 @default.
- W2608649154 creator A5068109132 @default.
- W2608649154 creator A5073926232 @default.
- W2608649154 creator A5074400049 @default.
- W2608649154 creator A5075089213 @default.
- W2608649154 creator A5075335149 @default.
- W2608649154 creator A5076611281 @default.
- W2608649154 creator A5082044378 @default.
- W2608649154 creator A5082694775 @default.
- W2608649154 creator A5088284813 @default.
- W2608649154 date "2017-04-24" @default.
- W2608649154 modified "2023-10-10" @default.
- W2608649154 title "Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction" @default.
- W2608649154 cites W1529592271 @default.
- W2608649154 cites W1570973990 @default.
- W2608649154 cites W1892239197 @default.
- W2608649154 cites W1975215468 @default.
- W2608649154 cites W1994831991 @default.
- W2608649154 cites W1995444593 @default.
- W2608649154 cites W1996424575 @default.
- W2608649154 cites W2009935355 @default.
- W2608649154 cites W2016535776 @default.
- W2608649154 cites W2016670036 @default.
- W2608649154 cites W2018509996 @default.
- W2608649154 cites W2019226618 @default.
- W2608649154 cites W2020871623 @default.
- W2608649154 cites W2026170688 @default.
- W2608649154 cites W2029774820 @default.
- W2608649154 cites W2035627251 @default.
- W2608649154 cites W2036391179 @default.
- W2608649154 cites W2039558597 @default.
- W2608649154 cites W2043828707 @default.
- W2608649154 cites W2043873569 @default.
- W2608649154 cites W2050622384 @default.
- W2608649154 cites W2056752509 @default.
- W2608649154 cites W2061980453 @default.
- W2608649154 cites W2066417811 @default.
- W2608649154 cites W2069663698 @default.
- W2608649154 cites W2075394689 @default.
- W2608649154 cites W2085337267 @default.
- W2608649154 cites W2089593092 @default.
- W2608649154 cites W2091851800 @default.
- W2608649154 cites W2100260504 @default.
- W2608649154 cites W2103645063 @default.
- W2608649154 cites W2105057119 @default.
- W2608649154 cites W2106204137 @default.
- W2608649154 cites W2108822380 @default.
- W2608649154 cites W2109148665 @default.
- W2608649154 cites W2110174113 @default.
- W2608649154 cites W2112056314 @default.
- W2608649154 cites W2115034481 @default.
- W2608649154 cites W2127211761 @default.
- W2608649154 cites W2130176433 @default.
- W2608649154 cites W2134172788 @default.
- W2608649154 cites W2134975242 @default.
- W2608649154 cites W2136490577 @default.
- W2608649154 cites W2136956348 @default.
- W2608649154 cites W2139742898 @default.
- W2608649154 cites W2139947959 @default.
- W2608649154 cites W2146179253 @default.
- W2608649154 cites W2147294760 @default.
- W2608649154 cites W2148652246 @default.
- W2608649154 cites W2153586956 @default.
- W2608649154 cites W2156760050 @default.
- W2608649154 cites W2157066764 @default.
- W2608649154 cites W2157271398 @default.
- W2608649154 cites W2159337738 @default.
- W2608649154 cites W2162869854 @default.
- W2608649154 cites W2165463320 @default.
- W2608649154 cites W2167440496 @default.
- W2608649154 cites W2219791300 @default.
- W2608649154 cites W2266396547 @default.
- W2608649154 cites W2296002833 @default.
- W2608649154 cites W2325201568 @default.
- W2608649154 cites W2344891838 @default.
- W2608649154 cites W2344995323 @default.
- W2608649154 cites W2401600644 @default.
- W2608649154 cites W2405183840 @default.
- W2608649154 cites W2471605942 @default.
- W2608649154 cites W2740802860 @default.